|Calculated MW||12664 Da|
|Application & Usage||Western blotting (0.5-4 µg/ml), However, the optimal concentrations should be determined individually.|
|Other Names||B-cell attracting chemokine-1, B-cell attracting chemokine1, B cell attracting chemokine-1|
|Formulation||100 µg (0.5 mg/ml) affinity purified rabbit anti-human BCA polyclonal antibody in phosphate-buffered saline (PBS) containing 30% glycerol, 0.5% BSA, and 0.01% thimerosal.|
|Handling||The antibody solution should be gently mixed before use.|
|Reconstitution & Storage||-20 °C|
|Precautions||BCA-1 (BLC/CXCL13) Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||BCA1, BLC, SCYB13|
|Function||Chemotactic for B-lymphocytes but not for T-lymphocytes, monocytes and neutrophils. Does not induce calcium release in B- lymphocytes. Binds to BLR1/CXCR5.|
|Tissue Location||Highest levels in liver, followed by spleen, lymph node, appendix and stomach. Low levels in salivary gland, mammary gland and fetal spleen|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Human BCA-1 (B Cell-Attracting chemokine 1), is also known as BLC or CXCL13. It is a recently identified new CXC chemokines. Human BCA-1 is a highly effective attractant for human blood B lymphocytes. The antibody recognizes a10.1 kDa of recombinant human BCA-1 protein (Cat. #:4001-100)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.